Stabilization of the MDM2 oncoprotein by mutant p53

被引:58
|
作者
Peng, YH
Chen, LH
Li, CG
Lu, WG
Agrawal, S
Chen, JD
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA
[2] Hybridon Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1074/jbc.C000781200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MDM2 is a short-lived protein that regulates p53 degradation. We report here that transient coexpression of MDM2 and several p53 hotspot mutants resulted in stabilization and increased expression of MDM2. Ectopic expression of the mutant p53(175H) allele by recombinant adenovirus infection or stable transfection also stabilized endogenous MDM2 in p53-null cells. A panel of human tumor cell lines expressing different endogenous mutant p53 alleles also contained stabilized nuclear MDM2 at elevated levels when compared with p53 null cells. MDM2 was present in complexes with mutant p53 in tumor cells, and stabilization of MDM2 required direct binding to mutant p53. These results reveal a novel property of mutant p53 and a unique feature of tumors with p53 missense mutations. Accumulation of stable MDM2 may contribute to tumorigenesis through its p53-independent transforming functions.
引用
收藏
页码:6874 / 6878
页数:5
相关论文
共 50 条
  • [1] Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
    Peng, YH
    Chen, LH
    Li, CG
    Lu, WG
    Chen, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) : 40583 - 40590
  • [2] The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
    C L Brooks
    M Li
    M Hu
    Y Shi
    W Gu
    [J]. Oncogene, 2007, 26 : 7262 - 7266
  • [3] Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
    Wiech, Milena
    Olszewski, Maciej B.
    Tracz-Gaszewska, Zuzanna
    Wawrzynow, Bartosz
    Zylicz, Maciej
    Zylicz, Alicja
    [J]. PLOS ONE, 2012, 7 (12):
  • [4] The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
    Mayo, LD
    Donner, DB
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (09) : 462 - 467
  • [5] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [6] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [7] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    [J]. BLOOD, 2023, 141 (11) : 1237 - 1238
  • [8] Binding of an inhibitor of the p53/MDM2 interaction to MDM2
    Duncan, SJ
    Cooper, MA
    Williams, DH
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 316 - 317
  • [9] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Christine Wasylyk
    Roberto Salvi
    Manuela Argentini
    Christine Dureuil
    Isabelle Delumeau
    Joseph Abecassis
    Laurent Debussche
    Bohdan Wasylyk
    [J]. Oncogene, 1999, 18 : 1921 - 1934
  • [10] p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
    Wasylyk, C
    Salvi, R
    Argentini, M
    Dureuil, C
    Delumeau, I
    Abecassis, J
    Debussche, L
    Wasylyk, B
    [J]. ONCOGENE, 1999, 18 (11) : 1921 - 1934